Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eleanor M. |
RCV003315277 | SCV005088638 | benign | Acute myeloid leukemia | 2023-07-22 | criteria provided, single submitter | research | The genetic Variant 'Arg250Trp' within the KLK2 Gene is too frequent to be classified as pathogenic, according to the ACMG guidelines (Richards et al., 2015) this variant meets the following criteria: BA1 (Stand Alone), as it is present in GnomAD exomes with an allele frequency of 0.243, which in turn, is greater than the minimum threshold requirement of >0.05 (with good coverage in gnomAD exomes = 42.9). It also satisfies additional supportive ACMG criteria, such as BP4 (benign-supportive ) with in-silico predictions classifying this variant as 'very strong benign' (meta-score (MetaRNN = 0.000294), which is less than the 0.00692 threshold cut-off. Lastly, an additional "benign supportive" BP6 criterion also been satisfied, due to independent review by Uniprot (VAR_020178) which assessed and classified this variant as 'Likely Benign/Benign' (LB/B). I also refer to a previous study with Meng. et al. (2023) which asserts rs198977 (genotype TT) as being 'associated with an increased risk of AML susceptibility'. However, this study seriously lacks the sufficient and robust sample size required to reach an appropriate conclusion (specifically in respect to the size of the TT genotype sub-group. This in turn, may result in a lower statistical power and yield unreliable estimates regarding the disease-association in question. Moreover there is no mention of specific population demographics used in the study, and this further raises questions about the population diversity recruited in this study. Notwithstanding, the current lack of in-vitro & in-vivo studies to support their results. This means results may suffer a serious lack of reproducibility relating to proving the variant-disease association relating to these results, let alone the specific genotype relating to the variant and the disease. In conclusion the high allele frequency of 0.243 effectively disqualifies this variant from being classified as pathogenic, in accordance with ACMG guidelines and current evidence available (at the time of this variant classification). |
| Shandong Key Laboratory of Immunohematology, |
RCV003315277 | SCV004012899 | pathogenic | Acute myeloid leukemia | no assertion criteria provided | research |